IL2 and Alzheimer disease: Although these IL2-mediating peptides might require T-cell intervention to have a more significant effect, IL2 treatments are beneficial in targeting activated astrocytes and Aβ fibrils (Alves et al., 2017), which could be beneficial in treatments for AD.